Cargando…
Effectiveness of the Original COVID-19 Vaccine against COVID-19 Exacerbations during the Omicron Wave: A Population-based Study in Okayama, Japan
INTRODUCTION: In Japan, approximately 97 million individuals have received their primary two doses of coronavirus disease 2019 (COVID-19) vaccine at the end of 2022. In this study, we aim to examine the effectiveness of the primary vaccines and compare its efficacy to booster vaccine shots in terms...
Autores principales: | Matsumoto, Naomi, Mitsuhashi, Toshiharu, Matsuo, Rumi, Kadowaki, Tomoka, Takao, Soshi, Yorifuji, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japan Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628327/ https://www.ncbi.nlm.nih.gov/pubmed/37941689 http://dx.doi.org/10.31662/jmaj.2023-0019 |
Ejemplares similares
-
Effect of mRNA Vaccines in Preventing COVID-19 Severe Pneumonia Among COVID-19 Patients in Japan
por: Matsuo, Rumi, et al.
Publicado: (2022) -
Antibody Titers After a Third and Fourth SARS-CoV-2 Vaccine Dose in Bizen City, Japan
por: Kadowaki, Tomoka, et al.
Publicado: (2023) -
Emergency Dispatches for Suicide Attempts During the COVID-19 Outbreak in Okayama, Japan: A Descriptive Epidemiological Study
por: Habu, Hiroshi, et al.
Publicado: (2021) -
Timing of REGEN-COV administration and progression to severe COVID-19
por: Kadowaki, Tomoka, et al.
Publicado: (2022) -
Excess All-Cause Mortality During the COVID-19 Outbreak in Japan
por: Yorifuji, Takashi, et al.
Publicado: (2021)